Invention Grant
- Patent Title: Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
-
Application No.: US17226199Application Date: 2021-04-09
-
Publication No.: US11964015B2Publication Date: 2024-04-23
- Inventor: Barbara Leuchs , Antonio Marchini , Jean Rommelaere , Assia Angelova , Dirk Jager , Wolfgang Wick , Michael Dahm
- Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM , RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
- Applicant Address: DE Heidelberg
- Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
- Current Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
- Current Assignee Address: DE Heidelberg; DE Heidelberg
- Agency: Duane Morris LLP
- Agent Thomas J. Kowalski; Deborah L. Lu
- Priority: EP 163555 2016.04.01 EP 020193 2016.05.27
- The original application number of the division: US16148257 2018.10.01
- Main IPC: A61K35/768
- IPC: A61K35/768 ; A61K39/395 ; A61K45/06 ; A61P35/00 ; C07K16/28 ; A61K39/00
Abstract:
The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer.
Public/Granted literature
- US20210228714A1 CANCER THERAPY WITH AN ONCOLYTIC VIRUS COMBINED WITH A CHECKPOINT INHIBITOR Public/Granted day:2021-07-29
Information query
IPC分类:
